Showing 6121-6130 of 8709 results for "".
- Topical PDE4 Inhibitor from Arcutis Shows Benefit in Seborrheic Dermatitishttps://practicaldermatology.com/news/topical-pde4-inhibitor-from-arcutis-shows-benefit-in-seborrheic-dermatitis/2460544/Positive topline data from a Phase 2 clinical trial suggest ARQ-154 (topical roflumilast foam) from Arcutis Biotherapeutics, Inc. is a potential treatment for seborrheic dermatitis. Study results show that roflumilast foam 0.3%
- Clearasil Steps Up to End Bullying, Support Skin Positivityhttps://practicaldermatology.com/news/clearasil-steps-up-to-end-bullying-support-skin-positivity/2460543/Clearasil is donating $25,000 to STOMP Out Bullying for National Bullying Prevention Month. As part of the partnership, Clearasil is also using its national platform to further the reach and impact of STOMP Out Bullying's efforts by sharing toolkits and educational resources wi
- Industry Responds to COVID-19: BTL Gives Backhttps://practicaldermatology.com/news/coping-with-covid-19-btl-gives-back/2460542/BTL is revamping several of their manufacturing facilities to provide face masks and ventilators to the medical community. As of September 2020, BTL's European manufacturing facilities have been producing ventilators and masks including 
- Marketing Exec Lizette Williams Joins RealSelf’s Boardhttps://practicaldermatology.com/news/lizette-williams-global-head-of-vertical-solutions-marketing-at-facebook-joins-realselfs-board/2460540/Marketing and advertising executive Lizette Williams is the newest member of RealSelf’s Board of Directors. Ms. Williams serves as the Global Head of Vertical Solutions Marketing at Facebook. Prior to Facebook she has worked in major marketing roles at McDonald's, Kimberl
- Tattoos Impair Sweating, May Increase Risk of Heat-related Injuryhttps://practicaldermatology.com/news/tattoos-impair-sweating-may-increase-risk-of-heat-related-injury/2460539/New research finds that tattooed skin does not sweat as much as non-inked areas, which may have implications for the body’s ability to cool in people with extensive tattooing.
- Medimetriks Streamlines MM36 AD Development Programhttps://practicaldermatology.com/news/medimetriks-streamlines-mm36-ad-development-program/2460532/Medimetriks Pharmaceuticals, Inc. is moving forward with its MM36 (difamilast) Atopic Dermatitis Development Program following a meeting with the U.S. Food and Drug Administration (FDA). Medimetriks is now preparing to conduct a s
- Amytrx Therapeutics Comes Out of the Gate Strong with Lead Program AMTX-100, Clinical Development Planshttps://practicaldermatology.com/news/amytrx-therapeutics-comes-out-of-the-gate-strong-with-lead-program-amtx-100-clinical-development-plans/2460531/Amytrx Therapeutics, Inc. is on the move. Founded in 2014, Nashville-based Amytrx is developing novel therapies for inflammatory diseases with lead program AMTX-100 currently in clinical development for dermatologic indications. AMTX-100 is a new anti-inflammatory therape
- Lilly Launches Digital Health Open Innovation Challenge to Help Transform AD Carehttps://practicaldermatology.com/news/lilly-launches-digital-health-open-innovation-challenge-to-help-transform-ad-care/2460529/Eli Lilly and Company is launching an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions to help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Der
- First Patient Enrolled in AVITA Therapeutic’s Pivotal Study of RECELL System for Vitiligohttps://practicaldermatology.com/news/first-patient-enrolled-in-avita-therapeutics-pivotal-study-of-recell-system-for-vitiligo/2460528/AVITA Therapeutics, Inc. a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs initiated its pivotal study assessing the use of the RECELL System to treat stable vitiligo with th
- Call for Entries: Sanofi Genzyme and Regeneron Launches 2020 ‘Agents of Change’ AD Challengehttps://practicaldermatology.com/news/call-for-entries-sanofi-genzyme-and-regeneron-launches-2020-agents-of-change-ad-challenge/2460527/In recognition World Atopic Dermatitis (AD) Day, Sanofi Genzyme and Regeneron are launching the 2020 ‘Agents of Change’ AD Challenge, a